XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenue $ 3,312,769 $ 3,153,963 $ 2,928,738
Salaries, wages and benefits (including equity-based compensation expense of $31,708, $37,113, and $32,289, respectively) 1,820,703 1,691,024 1,572,330
Professional fees 195,475 189,706 176,013
Supplies 118,047 112,713 105,992
Rents and leases 48,022 47,861 46,552
Other operating expenses 553,308 440,788 388,906
Income from provider relief fund     (6,419)
Depreciation and amortization 189,249 149,595 132,349
Interest expense, net 138,864 116,368 82,125
Debt extinguishment costs 1,269    
Legal settlements expense 150,966   394,181
Loss on impairment 1,007,892 17,276 9,790
Gain on sale of property (8,715)   (9,747)
Transaction, legal and other costs 163,630 46,753 62,026
Total expenses 4,378,710 2,812,084 2,954,098
(Loss) income before income taxes (1,065,941) 341,879 (25,360)
Provision for (benefit from) income taxes 25,982 77,395 (9,699)
Net (loss) income (1,091,923) 264,484 (15,661)
Net income attributable to noncontrolling interests (10,849) (8,872) (6,006)
Net (loss) income attributable to Acadia Healthcare Company, Inc. $ (1,102,772) $ 255,612 $ (21,667)
(Loss) earnings per share attributable to Acadia Healthcare Company, Inc. stockholders:      
Basic $ (12.16) $ 2.79 $ (0.24)
Diluted $ (12.16) $ 2.78 $ (0.24)
Weighted-average shares outstanding:      
Basic 90,705 91,621 90,949
Diluted 90,705 92,059 90,949